The main risk is conversion, not relevance. Marvell has real AI-era products and customer access, but it still must turn a small number of very large programs into on-time, profitable volume while outside foundries, packaging partners and
hyperscaler customers retain real bargaining power. At this valuation, margin mix slippage, capacity constraints or a single program delay can matter more than another promising product announcement.